-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Vascular Health and Risk Management
(2,748,419) Views
Editor in Chief Professor Roland Asmar
1178-2048
Relationship between arterial stiffness and heart rate recovery in apparently healthy adults
Ding-Yu Fei, Ross Arena, James A Arrowood, Kenneth A Kraft
Vascular Health and Risk Management 2005, 1:85-89
29 January 2005
Folic acid: a marker of endothelial function in type 2 diabetes?
Arduino A Mangoni, Roy A Sherwood, Belinda Asonganyi, Emma L Ouldred, Stephen Thomas, Stephen HD Jackson
Vascular Health and Risk Management 2005, 1:79-83
29 January 2005
Restenosis after percutaneous angioplasty: the role of vascular inflammation
Martin Schillinger, Erich Minar
Vascular Health and Risk Management 2005, 1:73-78
29 January 2005
Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium
Hong Ding, Chris R Triggle
Vascular Health and Risk Management 2005, 1:55-71
29 January 2005
New anticoagulants for the prevention and treatment of venous thromboembolism
Simon J McRae, Jeffrey S Ginsberg
Vascular Health and Risk Management 2005, 1:41-53
13 May 2005
Ongoing clinical trials of the pleiotropic effects of statins
Jean Davignon, Lawrence A Leiter
Vascular Health and Risk Management 2005, 1:29-40
29 January 2005
In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease
Rabea Asleh, Andrew P Levy
Vascular Health and Risk Management 2005, 1:19-28
13 May 2005
Barriers to and strategies for effective blood pressure control
David Siegel
Vascular Health and Risk Management 2005, 1:9-14
29 January 2005
Opinion - Coxibs: can this class of drugs survive?
Reza Tabrizchi
Vascular Health and Risk Management 2005, 1:5-8
29 January 2005
Opinion - Reducing cardiovascular risk: too little, too late, too short-term
David Gray
Vascular Health and Risk Management 2005, 1:3-5
29 January 2005
Editorial ||FREE PAPER||
Reza Tabrizchi
Vascular Health and Risk Management 2005, 1:1-1
13 May 2005
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University




